Up-regulated HSP90 was an independent factor that led to higher risk of death from breast cancer in the HER2-/ER+ breast cancer subtype (P = 0.0042, n = 421, COXPH test, Table 3), with a trend of significantly higher risk of distant metastasis in this subtype (Table 3). Here, HSP90AA1 is linked to breast carcinoma.